Huan Qiu Wang·2025-10-03 02:50Core Viewpoint - Berkshire Hathaway has officially announced the acquisition of Occidental Petroleum's chemical business, OxyChem, for $9.7 billion in cash, marking a significant strategic move for both companies [1][3]. Group 1: Transaction Details - The acquisition of OxyChem represents Occidental Petroleum's largest asset sale in its history and is a crucial step in its strategy to reduce debt following several large acquisitions [3]. - Occidental plans to use $6.5 billion of the proceeds from the sale to pay down debt, aiming to achieve a target of "debt principal below $15 billion" by December 2023 after acquiring CrownRock [3]. - This transaction is Berkshire Hathaway's largest acquisition since the $13.7 billion purchase of Alleghany Insurance in 2022 and marks its second significant investment in the chemical sector [3]. Group 2: Strategic Implications - The acquisition is expected to strengthen Berkshire's financial position and aligns with Warren Buffett's investment philosophy of acquiring quality assets at low prices [3]. - OxyChem's business is seen as complementary to Berkshire's existing assets, enhancing its chemical portfolio [3]. - Berkshire's vice chairman, Greg Abel, expressed optimism about OxyChem becoming an operational subsidiary of the group and endorsed Occidental's decision to optimize its balance sheet [3]. Group 3: Market Reactions - Analysts from Roth MKM suggest that OxyChem could have supported Occidental's expansion, and its sale may hinder future free cash flow growth [4]. - Scotiabank analyst Paul Cheng indicated that the transaction price appears low, as he previously valued OxyChem at approximately $12 billion [4].